Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Quanterix CorporationNASDAQ: QTRX
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $6.4M rose 132.8% year over year, behind the +148.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 11.7% from the prior quarter. Over 3 fiscal years it compounded at +52.4% a year.
Context
- Depreciation & amortization amounted to 13.6% of revenue in FY2025, up 7.5 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +132.8% toward the trailing-twelve-month pace of +148.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 18.93M USD
- Year-over-year change
- +126.5%
- 4-year CAGR
- +40.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.93M | +126.5% |
| FY2024 | 2024-12-31 | 8.36M | -0.3% |
| FY2023 | 2023-12-31 | 8.38M | +56.6% |
| FY2022 | 2022-12-31 | 5.35M | +10.3% |
| FY2021 | 2021-12-31 | 4.85M | — |
Depreciation & Amortization vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 depreciation & amortization of $22.58M is the 2nd largest of the 11 companies compared; the peer median is $2.11M.
- Its year-over-year change of +148.0% is the highest of 11, against a peer median of +9.1%.
- Depreciation & amortization amounts to 15.6% of revenue for QTRX, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $29.62M | +15.3% | +22.3% | 10.3% | |
| LTM Mar 2026 | $22.58M | +148.0% | +52.4% | 15.6% | |
| LTM Mar 2026 | $20.37M | -2.6% | -4.2% | 5.8% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| LTM Mar 2026 | $4.31M | -7.1% | +33.4% | 7.5% | |
| LTM Mar 2026 | $2.74M | +63.9% | -5.7% | 2.3% | |
| LTM Mar 2026 | $1.48M | +102.1% | -54.8% | 3.6% | |
| LTM Mar 2026 | $777K | +15.6% | +22.4% | 1.3% | |
| LTM Mar 2026 | $690K | +3.1% | -11.8% | 0.9% | |
| LTM Mar 2026 | $531.13K | +15.1% | -4.3% | — | |
| LTM Mar 2026 | $103K | -90.0% | +10.5% | 0.2% | |
| Peer median (excluding QTRX) | $2.11M | +9.1% | -1.8% | 3.6% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (57.69M) | (96.7M) | (32.33M) | (38.53M) | (107.15M) |
| Depreciation & Amortization | 4.85M | 5.35M | 8.38M | 8.36M | 18.93M |
| Deferred Income Tax | 801K | (226K) | 0 | 0 | (5.87M) |
| Stock-Based Compensation | 15.98M | 15.44M | 16.76M | 19.99M | 20.72M |
| Change in Working Capital | (12.19M) | 2.07M | (11.8M) | (18.79M) | (2.35M) |
| Accounts Receivables | (6.85M) | 5.16M | (6.7M) | (7.7M) | 10.61M |
| Inventory | (8.09M) | 5.39M | (5.36M) | (6.68M) | 4.03M |
| Accounts Payables | 2.41M | (5.36M) | 1.19M | 723K | (528K) |
| Other Working Capital | 343K | (3.11M) | (933K) | (5.13M) | (16.47M) |
| Other Non-Cash Items | 340K | 25.79M | 92K | (6.19M) | (1.51M) |
| Operating Cash Flow | (47.91M) | (48.27M) | (18.9M) | (35.16M) | (77.24M) |
| Capital Expenditures | (13.62M) | (11.73M) | (3.79M) | (3.37M) | (2.61M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (93.23M) |
| Purchases of Investments | 0 | 0 | (175.61M) | (295.61M) | (69.76M) |
| Sales of Investments | 0 | 0 | 31M | 216.71M | 215.83M |
| Other Investing Activities | 7.28M | 520K | 0 | 0 | 0 |
| Investing Cash Flow | (6.34M) | (11.21M) | (148.4M) | (82.27M) | 50.23M |
| Debt Repayment | (7.74M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 269.72M | 2.31M | 2.89M | 3.07M | 738K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.82M | 0 | (198K) | (2.61M) | (1.45M) |
| Financing Cash Flow | 270.8M | 2.31M | 2.69M | 456K | (708K) |
| Effect of Forex Changes | (92K) | (538K) | 301K | (734K) | 1.57M |
| Net Change in Cash | 216.46M | (57.71M) | (164.31M) | (117.71M) | (26.14M) |
| Free Cash Flow | (61.52M) | (60M) | (22.69M) | (38.53M) | (79.85M) |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.